AInvest Newsletter
Daily stocks & crypto headlines, free to your inbox
Viatris to Participate in UBS and Jefferies Healthcare Conferences.
ByAinvest
Monday, Oct 13, 2025 7:17 am ET1min read
Viatris Inc., a global healthcare company, will participate in two upcoming healthcare conferences in November 2025. The company will participate in a fireside chat at the UBS Global Healthcare Conference 2025 on November 11 and at the Jefferies Global Healthcare Conference in London on November 18. Investors and the general public can listen to the sessions live at investor.viatris.com or access archived versions later.
Viatris Inc. (Nasdaq: VTRS), a leading global healthcare company, has announced its participation in two significant healthcare conferences in November 2025. The company will engage in fireside chats at both the UBS Global Healthcare Conference 2025 and the Jefferies Global Healthcare Conference in London. These events provide an opportunity for investors and the general public to gain insights into Viatris' strategic vision and recent developments.The UBS Global Healthcare Conference 2025 will take place on November 11, 2025, at 8:45 a.m. ET, where Viatris will participate in a fireside chat. The company will also take part in a fireside chat at the Jefferies Global Healthcare Conference in London on November 18, 2025, at 11:30 a.m. GMT / 6:30 a.m. ET. Both sessions will be accessible live at investor.viatris.com, with archived versions available for a limited time following the events [1][2][3].
Viatris Inc. is uniquely positioned to bridge the gap between generics and branded medicines, offering a comprehensive approach to global healthcare needs. With a mission to empower people worldwide to live healthier at every stage of life, Viatris provides access to high-quality medicines for approximately 1 billion patients annually [1][2][3].
The company's extensive portfolio of medicines, coupled with a robust global supply chain, allows it to reach more people when and where they need them. Viatris is headquartered in the U.S. with global centers in Pittsburgh, Shanghai, and Hyderabad, India [1][2][3].
Investors and the public are encouraged to tune in to these sessions to gain valuable insights into Viatris' strategic initiatives and future plans.
Ainvest News articles are AI-generated using advanced large language model (LLM) technology designed to analyze and synthesize publicly available data and news. While AI tools assist in producing initial drafts and insights, all AI generated content published on Ainvest is subject to comprehensive human editorial review before publication. A designated human editor reviews, verifies, and approves each article for factual accuracy, coherence, and compliance with AInvest Fintech Inc’s editorial and disclosure standards.
Despite these review procedures, the information provided may still contain inaccuracies, incomplete data, or time sensitive references due to the inherent limitations of AI generated analysis and evolving changes. The material is provided strictly for informational and educational purposes and does not constitute personalized investment, legal, or financial advice. Readers should independently verify all facts, figures, and statements before making any decision based on this content.
AInvest Fintech Inc. its affiliates, and partners accept no liability or responsibility for any direct or consequential losses arising from reliance on this content. All articles and analyses are subject to revision, update, or removal without prior notice to maintain accuracy and integrity in our publications.
Comments
No comments yet